Innohale Therapeutics Israeli Company

Innohale Therapeutics develops inhaled nitric oxide (iNO) delivery solutions for the treatment of respiratory conditions from many etiologies (including COVID-19) and severe lung infections. The technology produces iNO from ambient air, which improves treatment accuracy and reduces costs and logistics burden.

Health Tech & Life Sciences Health Care Medical Therapeutics

Alternatives

No alternatives listed yet.

Suggest an Alternative

Name *

URL *

Founders

Dan Rappaport

Office Locations

Tel Aviv, Israel

References

[1]

finder.startupnationcentral.org - https://finder.startupnationcentral.org/company_page/innohale-therapeutics

[2]

crunchbase.com - https://www.crunchbase.com/organization/innohale-therapeutics

External links are provided for reference and verification purposes.